Virtual Exhibit Hall Booth-UCLA-Urogen

UroGen

Meeting ID: 895 2208 2927
Passcode: 087136
Click here or the button above

JELMYTO™ is indicated for the treatment of adult patients with low-grade Upper Tract Urothelial Cancer (LG-UTUC)

JELMYTO has pass-through status in hospital outpatient department (HOPD) and ambulatory surgical center (ASC) settings

JELMYTO is an alkylating drug indicated for the treatment of adult patients with low-grade Upper Tract Urothelial Cancer (LG-UTUC)

0

Billing & Coding Guide

0

Patient Brochure